journal article·2022-08-02Open access

Synthesis and Characterization of Ceramide-Containing Liposomes as Membrane Models for Different T Cell Subpopulations

Sascha Eder, Claudia Hollmann, Putri Mandasari, Pia Wittmann, Fabian Schumacher, Burkhard Kleuser, Julian Fink, Jürgen Seibel, Jürgen Schneider-Schaulies, Christian Stigloher, Niklas Beyersdorf, Sofia Dembski

Abstract

A fine balance of regulatory (Treg) and conventional CD4+ T cells (Tconv) is required to prevent harmful immune responses, while at the same time ensuring the development of protective immunity against pathogens. As for many cellular processes, sphingolipid metabolism also crucially modulates the Treg/Tconv balance. However, our understanding of how sphingolipid metabolism is involved in T cell biology is still evolving and a better characterization of the tools at hand is required to advance the field. Therefore, we established a reductionist liposomal membrane model system to imitate the plasma membrane of mouse Treg and Tconv with regards to their ceramide content. We found that the capacity of membranes to incorporate externally added azide-functionalized ceramide positively correlated with the ceramide content of the liposomes. Moreover, we studied the impact of the different liposomal preparations on primary mouse splenocytes in vitro. The addition of liposomes to resting, but not activated, splenocytes maintained viability with liposomes containing high amounts of C16-ceramide being most efficient. Our data thus suggest that differences in ceramide post-incorporation into Treg and Tconv reflect differences in the ceramide content of cellular membranes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Sphingolipid Metabolism and Signaling · Lipid Membrane Structure and Behavior · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Fraunhofer Institute for Silicate Research, ISC, 97082 Würzburg, Germany

Institute for Virology and Immunobiology, University of Würzburg, 97078 Würzburg, Germany

Institute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany

Institute of Organic Chemistry, University of Würzburg, 97074 Würzburg, Germany

Imaging Core Facility of the Biocenter, University of Würzburg, 97074 Würzburg, Germany

Department Tissue Engineering and Regenerative Medicine, University Hospital, 97070 Würzburg, Germany

Funding

the German Research Foundation (DFG) within RTG 2581 SphingoINF (417857878—projects 3, 6 and 9) · Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—426173797

References (38)

Show source-provided references
1. Membrane lipids: Where they are and how they behave10.1038/nrm2330 ↗
2. Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids10.1016/j.febslet.2009.10.058 ↗
3. Translational Approaches Targeting Ceramide Generation from Sphingomyelin in T Cells to Modulate Immunity in Humans10.3389/fimmu.2019.02363 ↗
4. Sphingomyelin breakdown in T cells: Role in activation, effector functions and immunoregulation10.1515/hsz-2014-0282 ↗
5. Phosphatase PP2A is requisite for the function of regulatory T cells10.1038/ni.3390 ↗
6. Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells10.4049/jimmunol.1600691 ↗
7. Inhibition of acid sphingomyelinase increases regulatory T cells in humans10.1093/braincomms/fcab020 ↗
8. Incorporation and visualization of azido-functionalized N-oleoyl serinol in Jurkat cells, mouse brain astrocytes, 3T3 fibroblasts and human brain microvascular endothelial cells10.1039/C6CC02879A ↗
9. Incorporation studies of clickable ceramides in Jurkat cell plasma membranes10.1039/C7CC01220A ↗
10. A Functionalized Sphingolipid Analogue for Studying Redistribution during Activation in Living T Cells10.4049/jimmunol.1502447 ↗
11. Siontorou, C.G., Nikoleli, G.-P., Nikolelis, D.P., and Karapetis, S.K. (2017). Artificial Lipid Membranes: Past, Present, and Future. Membranes, 7.10.3390/membranes7030038 ↗
12. Pucek, A., Tokarek, B., Waglewska, E., and Bazylińska, U. (2020). Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers. Pharmaceutics, 12.10.3390/pharmaceutics12060587 ↗
13. Lamichhane, N., Udayakumar, T.S., D’Souza, W.D., Simone, C.B., Raghavan, S.R., Polf, J., and Mahmood, J. (2018). Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery. Molecules, 23.10.3390/molecules23020288 ↗
14. Liposomes as models for membrane integrity10.1042/BST20190123 ↗
15. Diffusion of univalent ions across the lamellae of swollen phospholipids10.1016/S0022-2836(65)80093-6 ↗
16. Physicochemical profiling in drug research: A brief survey of the state-of-the-art of experimental techniques10.1007/PL00012496 ↗
17. Comparison of ΔpH- and Δφ-driven ATP synthesis catalyzed by the H + -ATPases from Escherichia coli or chloroplasts reconstituted into liposomes10.1016/S0014-5793(99)01060-1 ↗
18. Liposomes as a Model for the Biological Membrane: Studies on Daunorubicin Bilayer Interaction10.1007/s00232-011-9414-2 ↗
19. Topological restriction of SNARE-dependent membrane fusion10.1038/35025076 ↗
20. Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery10.1021/mp9000662 ↗
21. Reconstitution of Membrane Proteins into Model Membranes: Seeking Better Ways to Retain Protein Activities10.3390/ijms14011589 ↗
22. Lipid Rafts Reconstituted in Model Membranes10.1016/S0006-3495(01)76114-0 ↗
23. Membrane microdomains: Role of ceramides in the maintenance of their structure and functions10.1016/j.bbamem.2008.10.026 ↗
24. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes10.1126/science.1153124 ↗
25. MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells10.1016/j.immuni.2014.05.019 ↗
26. NIH Image to ImageJ: 25 Years of image analysis10.1038/nmeth.2089 ↗
27. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro10.1194/jlr.RA120000682 ↗
28. Characterization and Application of a New Optical Probe for Membrane Lipid Domains10.1529/biophysj.105.072884 ↗
29. Quantitative imaging of membrane lipid order in cells and organisms10.1038/nprot.2011.419 ↗
30. Click reactions with functional sphingolipids10.1515/hsz-2018-0169 ↗
31. Preparation and characterization of ceramide-based liposomes with high fusion activity and high membrane fluidity10.1016/j.colsurfb.2009.05.002 ↗
32. Lipid nanoparticles for mRNA delivery10.1038/s41578-021-00358-0 ↗
33. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): Implications for lipid raft structure and function10.1074/jbc.M309992200 ↗
34. Ceramide-C16 Is a Versatile Modulator of Phosphatidylethanolamine Polymorphism10.1016/j.bpj.2017.04.047 ↗
35. The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes10.1016/j.bbamem.2009.04.002 ↗
36. Ceramide and apoptosis: Exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer10.2174/187152012800228661 ↗
37. Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma10.1136/jitc-2020-000668 ↗
38. Hollmann, C.B. (2017). Role of the Acid Sphingomyelinase in Anti-Viral T Cell Responses in a Measles Virus Infection Model. [Ph.D. Thesis, Universität Würzburg].